Key result
Elevated discharge levels of cTn I (>24 ng/L) and NT-proBNP (>350 ng/L) were associated with increased risk for 1-year mortality and heart failure-related readmission.
Why the study?
Does the combination of NT-proBNP and high sensitive cTn I predict mortality and HF-related readmission in patients with acute heart failure?
Cohort (n=610)
No
Does the combination of NT-proBNP and high sensitive cTn I predict mortality and HF-related readmission in patients with acute heart failure?
Answers are grounded in this paper and cite their sources.
Elevated discharge levels and serial increases of NT-proBNP and high-sensitivity cTn I are independent and complementary predictors of mortality and readmission in acute heart failure.
BACKGROUND: N-terminal proBNP (NT-proBNP) and cardiac troponin I (cTn I) are widely used for the diagnosis of myocardial injury, but have not been used for routine evaluation in heart failure (HF) population. AIMS: To evaluate the prognostic utility of combination of NT-proBNP and cTn I in patients with HF, including serial NT-proBNP/cTn I measurements and discharge NT-proBNP/cTn I levels. PATIENTS AND METHODS: A total of 610 patients presenting in our emergency department for acute HF were studied. The mortality and HF-related readmission were endpoints in the study. NT-proBNP and cTn I were tested on admission including first 5 consecutive days, and on discharge. RESULTS: A discharge cTn I cut-off value at 24 ng/L and discharge NT-proBNP cut-off value at 350 ng/L were determined. The cTn I level more than 24 ng/L and NT-proBNP level more than 350 ng/L are associated with increased risk for mortality and readmission (p < 0.01). The mortality and HF-related readmission was significantly increased in patients with high cTn I + high NT-proBNP (p < 0.05), high cTn I + low NT-proBNP (p < 0.05), and low cTn I + high NT-proBNP (p < 0.0%). The increased cTn I or increased NT-proBNP measured in the first 5 consecutive days were significantly associated with 60-day HF-related events (p < 0.05), but the serial measurements did not have a predictive value of 1-year HF outcome. CONCLUSION: This study demonstrates that elevations of discharge cTn I and NT-proBNP are associated with increased 1-year mortality and HF-related readmission. Patients with increasing serial cTnI and NT-proBNP had increased risk for 60-day HF-related events. The two markers can act as independent predicators, and complete each other in prognostic utility of HF patients.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2016) conducted a cohort in Acute heart failure (n=610). Elevated discharge cTn I (>24 ng/L) and NT-proBNP (>350 ng/L) vs. Low cTn I and low NT-proBNP was evaluated on Mortality and HF-related readmission (p=<0.01). Elevated discharge levels of cTn I (>24 ng/L) and NT-proBNP (>350 ng/L) were associated with increased risk for 1-year mortality and heart failure-related readmission.
Synapse has enriched 10 related papers. Consider them for comparative context: